COMP <GO>
USNA vs JNJ // OPERATING MARGIN
USANA Health Sciences Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: USNA 5
— JNJ 7
▲ OPERATING MARGIN LEADER: JNJ
LAST: $14.34 (-1.91%) • MKT CAP: $265.0M
operating-margins
4.00%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
operating-margins
34.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USNA VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | USNA | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 78.30% | 67.90% | +10.40 | USNA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.90% | 25.50% | -17.60 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.7x | 18.5x | -15.80 | USNA | /valuation <GO> |
| Free Cash Flow Yield | 3.22% | 2.97% | +0.25 | USNA | /fcf-yield <GO> |
| Operating Margin ACTIVE | 4.00% | 34.70% | -30.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 28.50% | -27.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 6.00% | +2.30 | USNA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.56 | 5.59 | -2.03 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 62.1 | -16.81 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 23.0x | -0.10 | USNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $265.0M | $662.49B | -$662.23B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | USNA REV | JNJ REV | USNA GROSS % | JNJ GROSS % | USNA FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $925.3M | $94.19B | 78.3% | 67.9% | $8.5M | $19.70B |
| FY 2024 | $854.5M | $88.82B | 81.1% | 69.1% | $50.9M | $19.84B |
| FY 2023 | $921.0M | $85.16B | — | — | $70.6M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USNA // BETA —
JNJ // BETA 1.08